TELEREHAB: Non-inferiority Study of a Cardiac Tele-rehabilitation in Hybrid Form Compared to a Cardiac Rehabilitation

Sponsor
Clinique de la Mitterie (Other)
Overall Status
Recruiting
CT.gov ID
NCT05702216
Collaborator
(none)
70
1
2
12.9
5.4

Study Details

Study Description

Brief Summary

Cardiac tele-rehabilitation in a hybrid form can be a choise for the management of cardiovascular diseases. The aim is to increase the participation rate of patients in cardiac rehabilitation.

This new form of care can be as effective as traditional care.

Condition or Disease Intervention/Treatment Phase
  • Other: Rehabilitation
N/A

Detailed Description

The Covid-19 pandemic has had indirect effects on the health system, particularly in the management of cardiovascular diseases. Rehabilitation centres had to adapt their operation to the recommendations of health authorities. The choice appeared to be unavoidable: tele-rehabilitation care in a hybrid form. Moreover, Many patients do not participate at this kind of care. Many identified factors can explain this low rate of participation : a lack of proximity facilities does not promote patient participation.

The objective of this study is to demonstrate a comparable effectiveness between a cardiac telerehabilitation programme in hybrid form and a cardiac classic rehabilitation programme.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomization in two groups: a Hybrid Tele-pulmonary Rehabilitation group and a classic Rehabilitation group.Randomization in two groups: a Hybrid Tele-pulmonary Rehabilitation group and a classic Rehabilitation group.
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Étude de Non-infériorité d'un Programme de télé-réadaptation Cardiovasculaire Sous Une Forme Hybride Par Rapport à Une rééducation réadaptation Cardiovasculaire Classique
Actual Study Start Date :
Dec 5, 2022
Anticipated Primary Completion Date :
Dec 18, 2023
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: Cardiac rehabilitation

Other: Rehabilitation
Hybrid approach in cardiac telerehabilitation. Patients underwent 20 cardiac rehabilitation sessions: alternatively, patients underwent 10 classical cardiac rehabilitation sessions in the clinic and 10 cardiac telerehabilitation sessions at home.

Other: Cardiac Tele-rehabilitation

Tele cardiac rehabilitation in hybrid form

Other: Rehabilitation
Hybrid approach in cardiac telerehabilitation. Patients underwent 20 cardiac rehabilitation sessions: alternatively, patients underwent 10 classical cardiac rehabilitation sessions in the clinic and 10 cardiac telerehabilitation sessions at home.

Outcome Measures

Primary Outcome Measures

  1. 6-minute walk test [6 weeks before baseline]

    Distance covered in the 6-minute walk test

Secondary Outcome Measures

  1. Stress test [6 weeks before baseline]

    12-lead electrocardiogram

  2. Wall Squat Test [6 weeks before baseline]

    Muscular endurance

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18 ans

  • Patients with heart disease

  • Inclusion in the rehabilitation program

Exclusion Criteria:
  • Cardiac decompensation

  • No stabilised acute coronary syndrome

  • Decompensated heart failure

  • Severe ventricular rhythm disorders

  • Severe functional limitation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinique la Mitterie Lille France 59160

Sponsors and Collaborators

  • Clinique de la Mitterie

Investigators

  • Study Director: Michaël RACODON, Ph.D, CLINIQUE LA MITTERIE

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Michaël RACODON, clinical research coordinator, Clinique de la Mitterie
ClinicalTrials.gov Identifier:
NCT05702216
Other Study ID Numbers:
  • N° 2021-A03116-35
First Posted:
Jan 27, 2023
Last Update Posted:
Jan 30, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Michaël RACODON, clinical research coordinator, Clinique de la Mitterie

Study Results

No Results Posted as of Jan 30, 2023